Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04565457 · ClinicalTrials.gov registry record · NA

A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality

A NA study of Prostate Cancer and Head and Neck Cancers, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
43
Enrollment target
2
Study locations

NCT04565457: Completed NA study of Prostate Cancer and Head and Neck Cancers, sponsored by University of Colorado, Denver.

NCT04565457 is a NA study of Prostate Cancer and Head and Neck Cancers that has completed, run by University of Colorado, Denver. The registered enrollment target is 43 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04565457, a NA study of Prostate Cancer and Head and Neck Cancers, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
2
Study locations

Study Summary

This is Pilot study that investigates the CBCT(Cone beam computed tomography) image quality improvement provided by the 2D antiscatter grid technology. The primary objective is to assess the improvement in tissue visualization in an observer study, which will be conducted in a blinded fashion.

Primary Outcome

Ratio of HU error for standard clinical CBCT (iteratively reconstructed) relative to research CBCT with 2D antiscatter grid in photon therapy participants. HU error was assessed in corresponding regions of interest, and the ratio was estimated using a linear mixed-effects model. A ratio greater than 1 would indicate higher HU error in standard CBCT than in research CBCT. A ratio less than 1 would indicate higher HU error in research CBCT than in standard CBCT.

Interventions

  • DEVICE Research CBCT

Study Locations (2)

Colorado

  • University of Colorado Hospital - Aurora

Florida

  • University of Florida Health Proton Therapy Institute - Jacksonville

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2023-04-21
Est. Completion 2025-05-28
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT04565457 record still lists

NCT04565457 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Research CBCT is the first listed.

NCT04565457 reports a single indexed study location in Colorado, Florida.

Frequently Asked Questions

What is clinical trial NCT04565457 about?

NCT04565457 is a clinical study titled "A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality". This is Pilot study that investigates the CBCT(Cone beam computed tomography) image quality improvement provided by the 2D antiscatter grid technology. The primary objective is to assess the improvement in tissue visualization in an observer study, which will be conducted in a blinded fashion.

What is the current status of trial NCT04565457?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2023-04-21. Estimated completion is 2025-05-28.

What conditions does trial NCT04565457 study?

This clinical trial studies the following conditions: Prostate Cancer, Head and Neck Cancers, Upper Abdomen Cancers.

What interventions are being tested in trial NCT04565457?

The interventions under investigation include: Research CBCT (DEVICE).

Who is sponsoring clinical trial NCT04565457?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04565457 being conducted?

This trial has 2 study locations across Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04565457's enrollment target sits among peer trials

43 516th of 735 higher than 217 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04565457, the US trial registry maintained by the National Library of Medicine. NCT04565457 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.